Study Confirms Link Between SGLT2 inhibitors and Diabetic Ketoacidosis

WEDNESDAY, June 7, 2017 -- A new class of type 2 diabetes drugs called SGLT2 inhibitors could increase the risk of a rare, life-threatening complication of the disease called ketoacidosis, a new study warns. SGLT2 inhibitors include prescription...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news